Novo Nordisk Scheduled to Report Third Quarter Earnings Results
Novo Nordisk (NVO) is set to release its third-quarter financial results on Wednesday, November 4th, before the market opens. Investors are closely monitoring the report for updates regarding GLP-1 sales performance and future growth outlooks. The consensus estimates for the quarter place earnings per share at DKK 4.62, with revenue expected to reach approximately DKK 73.79 billion. This follows a comparison against previous quarterly performance as the market seeks clarity on the company's continued momentum in the weight-loss and diabetes medication sectors.
Tickers: $NVO
Topics: consensus estimates earnings announcement financial results